Allogeneic Stem Cell Donation
Authors:
- 7 January 2025
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 333 (1) , 81
Abstract
This JAMA Insights discusses allogenic stem cell donation, including the donation process and the effects of stem cell donation on donors.Keywords
This publication has 10 references indexed in Scilit:
- Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated DonorsJournal of Clinical Oncology, 2024
- Long-term outcomes of peripheral blood stem cell unrelated donors mobilized with filgrastimBlood Advances, 2024
- Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research RegistryTransplantation and Cellular Therapy, 2024
- Hematopoietic Stem-Cell Transplantation: Exploring the Latest Advances and Gaps in Disparities, Psychosocial and Symptom Management Interventions, and Chronic Graft-Versus-Host Disease CareAmerican Society of Clinical Oncology Educational Book, 2024
- Racial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantationBlood Advances, 2024
- Bone Marrow Harvest: A White Paper of Best Practices by the NMDP Marrow AllianceTransplantation and Cellular Therapy, 2024
- Suitability of haematopoietic cell donors: updated consensus recommendations from the WBMT standing committee on donor issuesThe Lancet Haematology, 2022
- Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTRBlood, 2019
- Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donorsHaematologica, 2018
- A review of the haematopoietic stem cell donation experience: is there room for improvement?Bone Marrow Transplantation, 2014